#Genhouse
GENHOUSE- videographer of the Nogi wedding and reception

#ZhangZhehan never entered the shrine, but it’s possible they did

Co-founder 张藩 posted a promo video that still has clips😳

GH caters to internet celebs and RAPPERS, like a recent proposal by 黄子韬Tao from EXO+
Full:
xhslink.com/a/vP1jeo76cSsZ
November 10, 2024 at 6:38 AM
February 25, 2026 at 10:59 AM
Feed: "Endpoints News"
By: Kyle LaHucik on Friday, February 13, 2026
Gilead gets cancer drug from China-based Genhouse for $80M upfront
Gilead is buying the global rights to an oral cancer drug from Genhouse Bio, a China-based biotech that filed for an IPO on the Hong Kong Stock Exchange last month.
endpoints.news
February 14, 2026 at 3:54 PM
Ok ok I’ll spill

There’s a few reasons 张藩 at Genhouse keeps posting about Wang Sicong—they’re in business with WANDA

Registered just after the Nogi wedding

They invested in a new business with a wedding planning company that partners with multiple Wanda hotels

xhslink.com/a/l75uIs1OUlvZ
November 10, 2024 at 7:30 PM
Signal or noise? > Gilead’s latest synthetic lethal therapy comes via $1.5B
deal with China’s Genhouse >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #competitivemarketing #pharmaceutical #biotech
Gilead’s latest synthetic lethal therapy comes via $1.5B deal with China’s Genhouse
Gilead has secured another synthetic lethal therapy, handing $80 million upfront for the global rights to a clinic-ready cancer drug from China’s Genhouse Bio.
dlvr.it
February 17, 2026 at 8:30 AM
LucidQuest Views >>> Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal Comment below! #LucidQuest #PharmaCI
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal Professional audiences only. Not investment research or […] The post Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal appeared first on LucidQuest Ventures.
dlvr.it
February 16, 2026 at 8:35 AM
Signal or noise? > Gilead gets cancer drug from China-based Genhouse for $80M
upfront >> Comment below! #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharmaceutical #pharma
Gilead gets cancer drug from China-based Genhouse for $80M upfront
Gilead is buying the global rights to an oral cancer drug from Genhouse Bio, a China-based biotech that filed for an IPO on the Hong Kong Stock Exchange last month. ...
dlvr.it
February 13, 2026 at 8:06 PM